SUBSCRIBE
SUBSCRIBE

IPO

Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Analysts Closely Watch Bay Area CytomX’s $80 Million IPO
October 8, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Nabriva, REGENXBIO, and Penumbra Set to Go Public This Week
September 14, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Bayer’s Spinoff Covestro to Go Public in Fourth Quarter
September 4, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Constellation Pharma Mulls IPO After Genentech Declines to Buy
August 25, 2015
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Step Aside Juno: World’s Richest Doctor Pulls Off Largest Biotech IPO Ever
July 29, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Bay Area’s Global Blood Therapeutics, Aimmune Jump on the IPO Wagon Seeking $115 Million Each
July 10, 2015
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Seres Therapeutics Raises $133M for State’s Second-Largest Bio IPO, As Rival OpenBiome Grows
June 26, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Ritter Takes a Run at Public Markers With $20M IPO
June 24, 2015
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Benitec Files $70 Million IPO As Gene Therapy Booms
June 23, 2015
 · 
4 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Billionaire’s Conkwest Aims for $172.5 Million IPO, While Neos Therapeutics Asks for $69 Million
June 22, 2015
 · 
2 min read
Load More
PRESS RELEASES
Press Releases
SpyGlass Pharma Announces Pricing of Initial Public Offering
February 6, 2026
 · 
3 min read
Press Releases
Agomab Announces Pricing of Initial Public Offering
February 6, 2026
 · 
4 min read
Press Releases
Veradermics Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
February 6, 2026
 · 
2 min read
Press Releases
Eikon Therapeutics Announces Pricing of Upsized Initial Public Offering
February 5, 2026
 · 
3 min read
Press Releases
Veradermics Announces Pricing of Upsized Initial Public Offering
February 4, 2026
 · 
4 min read
Press Releases
Agomab Announces Launch of Initial Public Offering
February 2, 2026
 · 
4 min read
Press Releases
Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
January 13, 2026
 · 
3 min read
Press Releases
Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025’s Largest Hong Kong Biotech IPO
December 30, 2025
 · 
12 min read
Press Releases
Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed
December 22, 2025
 · 
5 min read
Press Releases
Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
December 19, 2025
 · 
4 min read
Press Releases
Medline Announces Pricing of Upsized Initial Public Offering
December 17, 2025
 · 
4 min read
Press Releases
Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator
December 10, 2025
 · 
3 min read
Press Releases
Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering
December 8, 2025
 · 
4 min read
Press Releases
Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering
December 4, 2025
 · 
4 min read
Press Releases
Lumexa Imaging Announces Launch of Initial Public Offering
December 2, 2025
 · 
2 min read
Press Releases
Hemostemix Closes CDN$280,594 Private Placement
November 19, 2025
 · 
1 min read
Press Releases
NervGen Pharma Announces US$10 Million Non-Brokered Private Placement to Support Anticipated Nasdaq Listing and Advance NVG-291 Development
November 19, 2025
 · 
1 min read
Press Releases
Veri Medtech (VRHI) Files Registration Statement for Proposed Initial Public Offering
November 18, 2025
 · 
5 min read
Press Releases
BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter’s Option to Purchase Additional Shares
November 11, 2025
 · 
1 min read
Press Releases
Evommune Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
November 10, 2025
 · 
2 min read
Load More